MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ASMB has $235,508K in assets. $36,898K in debts. $31,120K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
664.67%
Quick Ratio
664.67%
Cash Ratio
88.92%
Debt to Asset Ratio
15.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Operating lease right-of-use (ro...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue from a related ...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
31,120 58,450 22,534 24,006
Marketable securities
195,481 189,656 210,023 50,974
Accounts receivable from collaboration with a related party
451 974 912 -
Prepaid expenses and other current assets
5,561 5,469 3,343 2,487
Total current assets
232,613 254,549 236,812 77,467
Property and equipment, net
214 221 229 219
Operating lease right-of-use (rou) assets
2,369 2,508 2,644 2,782
Other assets
312 312 312 312
Total assets
235,508 257,590 239,997 80,780
Accounts payable
1,129 1,171 1,683 743
Accrued research and development expenses
1,538 2,387 3,058 1,691
Other accrued expenses
2,664 7,749 5,728 3,407
Deferred revenue from a related party
29,076 36,904 42,363 40,917
Operating lease liabilities - short-term
590 569 548 533
Total current liabilities
34,997 48,780 53,380 47,291
Deferred revenue from a related party - long-term
-0 1,715 13,038
Operating lease liabilities - long-term
1,901 2,059 2,207 2,351
Total liabilities
36,898 50,839 57,302 62,680
Common stock, 0.001 par value 150,000,000 shares authorized as of march 31, 2026 and december 31, 2025 15,892,353 and 15,855,329 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
16 16 16 8
Additional paid-in capital
1,040,088 1,038,823 1,036,906 863,312
Accumulated other comprehensive loss
-368 -41 -90 -279
Accumulated deficit
-841,126 -832,047 -854,137 -844,941
Total stockholders' equity
198,610 206,751 182,695 18,100
Total liabilities and stockholders' equity
235,508 257,590 239,997 80,780
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$195,481K Cash and cashequivalents$31,120K Prepaid expenses andother current assets$5,561K Accounts receivable fromcollaboration with a related...$451K Total current assets$232,613K Operating leaseright-of-use (rou) assets$2,369K Other assets$312K Property and equipment,net$214K Total assets$235,508K Total liabilities andstockholders' equity$235,508K Total stockholders'equity$198,610K Total liabilities$36,898K Accumulated deficit-$841,126K Accumulated othercomprehensive loss-$368K Additional paid-in capital$1,040,088K Total currentliabilities$34,997K Operating leaseliabilities - long-term$1,901K Common stock, 0.001 parvalue 150,000,000...$16K Deferred revenue from arelated party$29,076K Other accruedexpenses$2,664K Accrued research anddevelopment expenses$1,538K Accounts payable$1,129K Operating leaseliabilities - short-term$590K

ASSEMBLY BIOSCIENCES, INC. (ASMB)

ASSEMBLY BIOSCIENCES, INC. (ASMB)